Vinblastine Injection Franchise in Ahmedabad

Anticancer Injection Supplier in Mumbai

Oncology Injection Distributor in Delhi

Hospital PCD Pharma Franchise in Bangalore

Vinblastine Injection Stockist in Hyderabad
Oncology Injection Manufacturer & Exporter in Chandigarh

Home/Products /vinblastine-10mg-injection

Vinbot 10 Injection

Composition : Vinblastine (10mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 10ml

Price : ₹1/-

Vinbot 10 Injection contains Vinblastine 10mg, a potent chemotherapeutic agent used for management of various cancers, including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, leukemia, and testicular cancer. It is primarily used in hospital and oncology care settings under strict medical supervision.

Vinblastine works by inhibiting microtubule formation during cell division, thereby stopping the growth of cancerous cells and inducing cell death. Its mechanism is critical for controlling rapidly dividing malignant cells.

This injection is commonly prescribed for cancer patients requiring combination chemotherapy regimens. Its parenteral form ensures rapid and controlled delivery, providing optimal therapeutic efficacy in clinical oncology protocols.

For PCD pharma franchise partners, Vinbot 10 Injection is a high-value oncology product, available at the best price for PCD pharma franchise. Its demand in hospital oncology departments, prescriber confidence, and critical role in chemotherapy protocols make it an essential addition to any oncology or anticancer medicine portfolio.

Read More

About the Product

Vinbot 10 Injection contains Vinblastine 10mg, a potent chemotherapeutic agent used for management of various cancers, including Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, leukemia, and testicular cancer. It is primarily used in hospital and oncology care settings under strict medical supervision.

Vinblastine works by inhibiting microtubule formation during cell division, thereby stopping the growth of cancerous cells and inducing cell death. Its mechanism is critical for controlling rapidly dividing malignant cells.

This injection is commonly prescribed for cancer patients requiring combination chemotherapy regimens. Its parenteral form ensures rapid and controlled delivery, providing optimal therapeutic efficacy in clinical oncology protocols.

For PCD pharma franchise partners, Vinbot 10 Injection is a high-value oncology product, available at the best price for PCD pharma franchise. Its demand in hospital oncology departments, prescriber confidence, and critical role in chemotherapy protocols make it an essential addition to any oncology or anticancer medicine portfolio.

Common side effects may include nausea, vomiting, hair loss, fatigue, and mild bone marrow suppression. Rare but serious effects include severe neutropenia, peripheral neuropathy, allergic reactions, and gastrointestinal disturbances. Patients should be monitored regularly during therapy.

Vinbot 10 Injection is indicated for the treatment of cancers such as Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, testicular cancer, breast cancer, and other malignancies as prescribed by an oncologist. It helps in reducing tumor size and controlling the progression of cancer.

Vinbot 10 Injection should be administered only by trained healthcare professionals in a hospital or clinical setting. Dosage and treatment schedules must be strictly followed. Patients should report any signs of infection, unusual bleeding, or neurological symptoms immediately to their doctor.

Store Vinbot 10 Injection in a cool, dry place away from direct sunlight. Keep the vial tightly closed and out of reach of children. Do not use if the solution is discolored or contains particulate matter.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation